In o n e set of studies, w e have evaluated the role of endogenous TGF-P responsiveness in the maintenance of the differentiated phenotype of myoblasts a n d osteoblasts. W e therefore abrogated the responsiveness t o TGF-P i n established osteoblasts a n d myoblasts that can differentiate into myoutubes in culture. O u r results indicate a n important role of continuous TGF-P responsiveness in these well-differentiated cell types. I n other studies w e focussed o n the biological activities of vgr-l/BMP-6, a TGF-P family member which is specifically expressed in hypertrophic cartilage, b u t for which no functional information is as yet available.
continuous TGF-P responsiveness in these well-differentiated cell types. I n other studies w e focussed o n the biological activities of vgr-l/BMP-6, a TGF-P family member which is specifically expressed in hypertrophic cartilage, b u t for which no functional information is as yet available.
Transfected C H O cells overexpressing murine vgr-1 /BMP-6 were derived a n d recombinant vgr-l/BMP-6 was purified to serve as a source of the factor thus allowing u s to evaluate its role in osteogenesis a n d chondrogenesis in culture. In addition, transfected CHO cells overexpressing vgr-l/BMP-6 were inoculated into mice a n d the effect of vgr-l/BMP-6 on the phenotype of the resulting tumors w a s evaluated by histological analysis. Studies of this type should allow u s to define the natural role of the different TGF-P family members in the mesenchymal differentiation pathways. Surgical biopsies from 27 girls and 18 boys aged between 2 and 8 ycars wcrc used to prcparc high density primary cultures of chondrocylcs in serum-free culture mcdjum. Thc chlldrcn were considered normal in tcrm of skeletal growlh. Cell mult~plication and collagcn type I1 biosynthesis and secretion by lhe cultured cells were studicd ,n the absencc or in the prcscncc of I O -'~M 17P estradiol or teslostcrone. Chondrocyte multiplication, pcrforrncd In thc presence of l0ngIml of bFGF, was never modified by the addition of sex stcro~d hormoncs. By contrast, when esuadiol or testosterone were added to the cells at conflucncy, a sign~ftcant increased of type I1 collagen peptide was recovered in the ucatcd cells as compared w~th non treated ones. Cycloheximide ( I O -~M ) did not completely inh~bit Ihe increasul arnounl of lype I1 collagen peptlde recovered in hormone ueated cells. At thc mRNA lcvcl, as cvaluatcd by northen blot analysis, the steroids induced only a two fold incrcasc of typc 11 collagcn transcripts. The stimulating effccl of 17P csuadiol was always higher than thc one of testosterone. A possible effect of testosterone through 11s mctabollc convcrslon Into estrogens was suggesled, sincc the cultured chondrocytes appeared to contain aromatasc acuvities. No significant increase of chondrocytc collagen content was observed whcn lhc steroid hormoncs were added during the division phase of lhe culmre. Inlcrlcukinc 1 (ILI) whkch is known lo slimulalc the collagcnase secretion by chondrocytes, was added a1 lhc conccnuation ol 50ng/ml, to confluent chondrocytcs cultured from two prepubertal g~rls. A srgnlflcanl decrease of chondrocyte collagen type I1 was found and was no1 obscrvcd in the prcscncc ol 17P estradiol added a1 I W~M during three days. Thcse dala suggcsl that scx stcrold hormones are acting on lhc differenliation more than the prolifcratlon of chondrocylcs. Scx stcro~d hormones may mainlam cartilage cell phenolype by modulating both the synthcs~s and lhc dcgradalion of chondrocyte specific proteins.
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BONE MASS GROWTH DURING NORMAL PUBERTAL DEVELOPMENT.
G.E. Theintz Bone mineral density (BMD, gr/cm2) and content (BMC, gr) were determined at the levels of the lumbar vertebrae (L2-LA), femoral neck (FN) and midfemoral shaft (FS) using DEX absorptiometly at 1-yr interval in 198 healthy adolescents (98 females, 100 males) aged 9-19 yrs. BMD/ BMC values were related to age, height, weight, pubertal stage and to environmental variables such as calcium intake and the level of physical activity. In females, the gain in BMDDMC was sustained from 11 to 14 yrs but fell dramatically after 16 yrs and/ or 2 yrs after menarche. In males, the BMDI BMC gain was elevated from 13 to 17 yrs and then declined markedly, remaining significant between 17 and 20 yrs for L2-L4 BMDDMC and FS BMD only. Large interindividual variations were observed between height increments and bone mass gain with a relationship evolving according t o a loop pattern. Multiple regression analysis showed that weight was the strongest predictor of bone mass at each site. Nutrition and exercise improved the R2 of the overall model by only 6% at L2-!A and 4.1% at FN. Their effect on FS was negligible (+0.7%). During the normal pubertal development of average subjects, the effects of environmental factors appear to be outweighed by the large gain of bone mass due to puberty itself. These effects should therefore be easier to demonstrate in prepubertal children: this point appears of relevance for future intervention programmes aiming at maximizing bone mass gain during growth. 
The mandate of t h e ITF was d e f i n e d i n o r d e r t o determine t h e outcome i n terms of f i n a l h e i g h t a t t a i n m e n t i n s h o r t normal c h i l d r e n o f normal b i r t h w e i g h t who have been t r e a t e d continuously w i t h GH f o r a t l e a s t t h r e e y e a r s . A f t e r c o n s i d e r a b l e d i s c u s s i o n , t h e ITF developed a q u e s t i o n n a i r e f o r t h i s purpose, which was provided t o a l l i n v e s t i g a t o r s who had i n d i c a t e d by p r e l i m i n a r y s u r v e y t h a t t h e y had d a t a t h a t c o u l d b e made a v a i l a b l e f o r a n a l v s i s . S e v e r a l s i~n i f i c a n t i s s u e s w e r e r e c o g n i z e d t h a t wo;ld make d a t a c o i l e c t i o n and a n a l y s i s d i f f i c u l t . These .included t h e l i m i t e d number of c h i l d r e n who have a t t a i n e d f i n a l h e i g h t , t h e i n f l u e n c e of puberty o n s e t o c c u r r i n q d u r i n g G H t h e r a p y , -t h e enormously v a r i a b l e t h a t have b e e n employed w i t h b o t h p i t u i t a r y -e x t r a c t e d and b i o s y n t h e t i c growth hormone, t h e absence of a s u i t a b l e c o n t r o l group t h a t would span t h e g e n e t i c h e t e r o g e n e i t y of t h e s t u d y p o p u l a t i o n s ,
and t h e i n t e r r u p t i o n of therapy i n some c h i l d r e n a s a r e s u l t of t h e C J D c r i s i s i n 1985. Data a n a l y s i s w i l l i n c l u d e i n i t i a l bone age (BA) and mid-parental h e i g h t t o a s s e s s g e n e t i c p o t e n t i a l , one-year pre-treatment growth v e l o c i t y (GV) t o determine h e i g h t SDS a t o n s e t , h e i g h t a t t a i n e d a t two y e a r s a f t e r i n i t i a t i o n of continuous t h e r a p y , and f i n a l h e i g h t a t t a i n e d a f t e r a t l e a s t a t o t a l of t h r e e y e a r s oE GH therapy (BA fused and/or G V < 2 cm/yr.). H i s t o r i c a l c o n t r o l s w i l l be developed from u n t r e a t e d normal s h o r t s t a t u r e c h i l d r e n who have reached a d u l t h e i g h t by a n a l y s i s of d a t a b a s e s i n s e v e r a l c o u n t r i e s , i n c l u d i n g Germany, Sweden, and Denmark. A comparative a n a l y s i s w i l l a l s o be made of t h o s e c h i l d r e n with t h e d i a g n o s i s of GHD t h a t have been t r e a t e d w i t h GH and a t t a i n e d f i n a l h e i g h t , b u t who r e t e s t a s 'normal' following d i s c o n t i n u a t i o n of GH therapy. It is a n t i c i p a t e d t h a t t h i s t a s k f o r c e w i l l be a b l e t o provide a t l e a s t a p r e l i m i n a r y f i n a l h e i g h t outcome statement i n regard t o s h o r t c h i l d r e n who have r e c e i v e d growth hormone f o r a s i g n i f i c a n t p e r i o d of t h e i r childhood. It w i l l a l s o recommend t h a t a s i m i l a r a n a l y s i s be c o n d u c t e d i n t h e f u t u r e i n r e g a r d t o p s y c h o l o g i c a l and e d u c a t i o n a l outcome v a r i a b l e s i n t h e s e c h i l d r e n .
HEIGHT DEVELOPMENT IN TURNER SYNDROME I T S ) : RESULTS OF AN INTERNATIONAL SURVEY CONDUCTED BY ESPE/LWPES. M.B.Ranke f o r t h e ESPE/LWPES, S e c t l o n f o r P a e d . E n d o c r . , U n i v . C h i l d r e n ' s H o s p l t a l , D-7400 T u e b i n g e n , G e r m a n y . T h u s , d a t a o n a d u l t h e i g h t , d r a w n f r o m p a t l e n t s w h o s e d i a g n o s i s w a s made v e r y l a t e , c a n n o t g o v e r n t h e h e i g h t p r o g n o s t i c s u s e d f o r p a t l e n t s who a r e r e c o g n i z e d much e a r l l e r .
R e c e n t a t t e m p t s t o i m p r o v e h e i g h t i n TS t h r o u g h g r o w t h h o r m o n e t h e r a p y h a v e stimulated w o r l d w i d e i n te r e s t I n t h e s p o n t a n e o u s g r o w t h a n d f i n a l h e i g h t o f t h e s e p a t l e n t s . Published d a t a show t h a t women w i t h TS r e a c h a mean h e i g h t o f a
H e i g h t p r o g n o s i s i n T S , t h e r e f o r e , n e e d s t o b e f u r t h e r i n d i v l d u a l l z e d b y t a k i n g p a r e n t a l h e i g h t , k a r y o t y p e , s l z e a t b i r t h , d e g r e e o f d y s m o r p h o l o g y , b o n e a g e a n d ethnically-representative g r o w t h c u r v e s l n t o c o n s i d e r a t r o n . C u r r e n t d a t a s u p p o r t s t.he v l e w t h a t . G H t h e r a p y c a n ~r n p r o v e b o t h h e l g h t I n c h i l d h o o d a n d ~n a d u l t l l f e ~n TS.
.A PREDICTION MODEL FOR THE FIRST YEAR GROWTH RESPONSE TO GROWTH HORMONE IN TURNER SYNDROME ITS1 BASED ON KIGS ( K a b i P h a r m a c l a I n t e r n a t i o n a l G r o w t h S t u d y ) DATA.
